COMPANY PROFILE

Enzymaster

Explore full profile

Innovative biocatalysis solutions for pharmaceutical and chemical industries, enhancing efficiency and sustainability

Ningbo, ChinaFounded 2018Biotech & Life Sciences

Valuation $100–250M Last recorded · 2022

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Enzymaster

Enzymaster is a company specializing in biocatalysis solutions, primarily serving clients in the pharmaceutical and chemical industries. The company operates in the global market, offering tailored enzyme development and biocatalytic process optimization services. Enzymaster's business model revolves around providing customized biocatalytic solutions that improve the efficiency and sustainability of chemical processes. The company generates revenue through service contracts, licensing agreements, and collaborative projects with industry partners. By leveraging advanced computational tools and extensive expertise in enzyme engineering, Enzymaster helps clients achieve higher yields, reduced costs, and environmentally friendly processes.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2018
Headquarters: Ningbo, China
Employees: 4
Open positions: None listed
Dealroom signal: 25.7/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES C✓Equity / VC	Jan 2022	$41M	$165M	Puhua Capital · Xiamen C&D · Yuansheng BioVenture	↗
SERIES B✓Equity / VC	Sep 2020	$6.9M	$28M	Puhua Capital · Yuansheng BioVenture · Xiamen C&D	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Enzymaster website traffic

Latest recorded traffic for Enzymaster is 1.1K monthly website visits, up 0% over the last three months. Enzymaster's team declined 20% over the past year.

Latest monthly visits1.1K 3-month web change0% 1-year team growth-20%

Monthly website visitsJan 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
IIIotech InternationalPatented molecular iodine oral and topical solutions	Boynton Beach, United States	Closed	—	$50K	—
ALAlderley Lighthouse LabsClinically led laboratory pathology and diagnostic testing services	Macclesfield, United Kingdom	Operational
NKNK:IODeveloping technologies to improve cancer treatment	London, United Kingdom	Operational
LTLirum TherapeuticsClinical-stage targeted therapies for oncology and autoimmune diseases	New York City, United States	Operational
APAplantexAplantex uses proprietary technology based on "omics" to produce a large catalog of high-value plant-based active ingredients for various markets	Montreal, Canada	Operational
AIAirBiometricsHelps to regain sovereignty over well-being	Castellón de la Plana, Spain	Operational
NENeuroCluesThe brain stethoscope providing CNS biomarkers in a Blink	Ottignies-Louvain-la-Neuve, Belgium	Operational
CHChemifyDigitizing chemistry by developing technology to convert chemical code into molecules and vice versa	Glasgow, United Kingdom	Operational